{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:50:46Z","timestamp":1784548246445,"version":"3.55.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00894-025-06303-0","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:52:23Z","timestamp":1738986743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Malaria parasite cysteine and aspartic proteases as key drug targets for antimalarial therapy"],"prefix":"10.1007","volume":"31","author":[{"given":"Akinwunmi O.","family":"Adeoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Lobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"6303_CR1","unstructured":"World Health Organization (2018) World Malaria Report 2018. World Health Organization, Geneva"},{"key":"6303_CR2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Pyae-Phyo A, Woodrow CJ (2018) Malaria. Lancet 391:1608\u20131621","journal-title":"Lancet"},{"key":"6303_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ (2019) Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis 19:338\u2013351","journal-title":"Lancet Infect Dis"},{"issue":"6872","key":"6303_CR4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","volume":"415","author":"J Sachs","year":"2002","unstructured":"Sachs J, Malaney P (2002) The economic and social burden of malaria. Nature 415(6872):680\u2013685","journal-title":"Nature"},{"key":"6303_CR5","first-page":"211","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Guidelines for the treatment of malaria, 2nd edn. WHO Press, Geneva, p 211","edition":"2"},{"key":"6303_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1475-2875-9-219","volume":"9","author":"TH Tang","year":"2010","unstructured":"Tang TH, Salas A, Ali-Tammam M, Mart\u00ednez MC, Lanza M, Arroyo E, Rubio JM (2010) First case of detection of Plasmodium knowlesi in Spain by Real-Time PCR in a traveler from Southeast Asia. Malaria J 9:219","journal-title":"Malaria J"},{"issue":"8","key":"6303_CR7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ (2004) Antimalarial drug resistance. J Clin Invest 113(8):1084\u20131092","journal-title":"J Clin Invest"},{"issue":"7086","key":"6303_CR8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/440852b","volume":"440","author":"N Towie","year":"2006","unstructured":"Towie N (2006) Malaria breakthrough raises the specter of drug resistance. Nature 440(7086):852\u2013853","journal-title":"Nature"},{"issue":"4","key":"6303_CR9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","volume":"94","author":"W Sirawaraporn","year":"1997","unstructured":"Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV (1997) Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci U S A 94(4):1124\u20139","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6303_CR10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/molbev\/msh205","volume":"21","author":"RE Martin","year":"2004","unstructured":"Martin RE, Kirk K (2004) The malaria parasite\u2019s chloroquine resistance transporter is a member of the drug\/metabolite transporter superfamily. Mol Biol Evol 21(10):1938\u20131949","journal-title":"Mol Biol Evol"},{"issue":"6","key":"6303_CR11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/jac\/dkq090","volume":"65","author":"MK Das","year":"2010","unstructured":"Das MK, Lumb V, Mittra P, Singh SS, Dash AP, Sharma YD (2010) High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India. J Antimicrob Chemother 65(6):1258\u20131261","journal-title":"J Antimicrob Chemother"},{"issue":"27","key":"6303_CR12","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","volume":"274","author":"AV Pandey","year":"1999","unstructured":"Pandey AV, Tekwani BL, Singh RL, Chauhan VS (1999) Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasites. J Biol Chem 274(27):19383\u201319388","journal-title":"J Biol Chem"},{"issue":"6951","key":"6303_CR13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O\u2019Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424(6951):957\u2013961","journal-title":"Nature"},{"key":"6303_CR14","first-page":"123","volume":"84","author":"G Padmanaban","year":"2003","unstructured":"Padmanaban G (2003) Drug targets in malaria parasites. Adv Biochem Eng Biotechnol 84:123\u2013141","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"3","key":"6303_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1110\/ps.0228103","volume":"12","author":"YA Sabnis","year":"2003","unstructured":"Sabnis YA, Desai PV, Rosenthal PJ, Avery MA (2003) Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies. Protein Sci 12(3):501\u2013509","journal-title":"Protein Sci"},{"key":"6303_CR16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.TM118.004156","volume":"294","author":"JS Bond","year":"2019","unstructured":"Bond JS (2019) Proteases: history, discovery, and roles in health and disease. J Biol Chem 294:1643\u20131651","journal-title":"J Biol Chem"},{"key":"6303_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pro.3948","volume":"30","author":"ND Rawlings","year":"2021","unstructured":"Rawlings ND, Bateman A (2021) How to use the MEROPS database and website to help understand peptidase specificity. Protein Sci 30:83\u201392","journal-title":"Protein Sci"},{"key":"6303_CR18","volume-title":"Handbook of proteolytic enzymes introduction","author":"AJ Barrett","year":"2013","unstructured":"Barrett AJ, Rawlings ND, Salvesen G, Woessner JF (2013) Handbook of proteolytic enzymes introduction, 3rd edn. Academic Press, Boston, MA, USA; London, UK","edition":"3"},{"issue":"37","key":"6303_CR19","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","volume":"275","author":"BR Shenai","year":"2000","unstructured":"Shenai BR, Sijwali PS, Singh A, Rosenthal PJ (2000) Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem 275(37):29000\u201329010","journal-title":"J Biol Chem"},{"issue":"13\u201314","key":"6303_CR20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ijpara.2004.10.003","volume":"34","author":"PJ Rosenthal","year":"2004","unstructured":"Rosenthal PJ (2004) Cysteine proteases of malaria parasites. Int J Parasitol 34(13\u201314):1489\u20131499","journal-title":"Int J Parasitol"},{"issue":"2","key":"6303_CR21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00062752-200203000-00010","volume":"9","author":"PJ Rosenthal","year":"2002","unstructured":"Rosenthal PJ (2002) Hydrolysis of erythrocyte proteins by proteases of malaria parasites. Curr Opin Hematol 9(2):140\u2013145","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"6303_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molbiopara.2006.06.013","volume":"150","author":"PS Sijwali","year":"2006","unstructured":"Sijwali PS, Koo J, Singh N, Rosenthal PJ (2006) Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol Biochem Parasitol 150(1):96\u2013106","journal-title":"Mol Biochem Parasitol"},{"issue":"7281","key":"6303_CR23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature08728","volume":"463","author":"JA Boddey","year":"2010","unstructured":"Boddey JA, Hodder AN, Gunther S, Gilson PR, Patsiouras H, Kapp EA (2010) An aspartyl protease directs malaria effector proteins to the host cell. Nature 463(7281):627\u2013631","journal-title":"Nature"},{"issue":"7281","key":"6303_CR24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature08726","volume":"463","author":"I Russo","year":"2010","unstructured":"Russo I, Babbitt S, Muralidharan V, Butler T, Oksman A, Goldberg DE (2010) Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte. Nature 463(7281):632\u2013636","journal-title":"Nature"},{"issue":"1","key":"6303_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molbiopara.2014.05.004","volume":"195","author":"BS Mastan","year":"2014","unstructured":"Mastan BS, Kumari A, Gupta D, Mishra S, Kumar KA (2014) Gene disruption reveals a dispensable role for plasmepsin VII in the Plasmodium berghei life cycle. Mol Biochem Parasitol 195(1):10\u201313","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"6303_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(03)00137-3","volume":"130","author":"JB Dame","year":"2003","unstructured":"Dame JB, Yowell CA, Omara-Opyene L, Carlton JM, Cooper RA, Li T (2003) Plasmepsin 4, the food vacuole aspartic proteinase found in all plasmodium spp. Infecting man Mol Biochem Parasitol 130(1):1\u201312","journal-title":"Infecting man Mol Biochem Parasitol"},{"issue":"11","key":"6303_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1471-4922(01)02037-2","volume":"17","author":"GH Coombs","year":"2001","unstructured":"Coombs GH, Goldberg DE, Klemba M, Berry C, Kay J, Mottram JC (2001) Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol 17(11):532\u2013537","journal-title":"Trends Parasitol"},{"issue":"2","key":"6303_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molbiopara.2010.05.007","volume":"173","author":"JA Naughton","year":"2010","unstructured":"Naughton JA, Nasizadeh S, Bell A (2010) Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol 173(2):81\u201387","journal-title":"Mol Biochem Parasitol"},{"issue":"10","key":"6303_CR29","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2002-08-2654","volume":"101","author":"VL Lew","year":"2003","unstructured":"Lew VL, Tiffert T, Ginsburg H (2003) Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum-infected red blood cells. Blood 101(10):4189\u20134194","journal-title":"Blood"},{"issue":"2","key":"6303_CR30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-6851(01)00427-3","volume":"119","author":"M Krugliak","year":"2002","unstructured":"Krugliak M, Zhang J, Ginsburg H (2002) Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins. Mol Biochem Parasitol 119(2):249\u2013256","journal-title":"Mol Biochem Parasitol"},{"issue":"12","key":"6303_CR31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pt.2004.10.001","volume":"20","author":"SM Khan","year":"2004","unstructured":"Khan SM, Waters AP (2004) Malaria parasite transmission stages: an update. Trends Parasitol 20(12):575\u2013580","journal-title":"Trends Parasitol"},{"issue":"1","key":"6303_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568005043480925","volume":"4","author":"K Hayton","year":"2004","unstructured":"Hayton K, Su XZ (2004) Genetic and biochemical aspects of drug resistance in malaria parasites. Curr Drug Targets Infect Disord 4(1):1\u201310","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"11","key":"6303_CR33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1568026023392986","volume":"2","author":"JN Dominguez","year":"2002","unstructured":"Dominguez JN (2002) Chemotherapeutic agents against malaria: what next after chloroquine? Curr Top Med Chem 2(11):1173\u20131185","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"6303_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijantimicag.2007.01.002","volume":"30","author":"S Jana","year":"2007","unstructured":"Jana S, Paliwal J (2007) Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents 30(1):4\u201310","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"6303_CR35","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1073\/pnas.051629998","volume":"98","author":"J Jelenska","year":"2001","unstructured":"Jelenska J, Crawford MJ, Harb OS, Zuther E, Haselkorn R, Roos DS, Gornicki P (2001) Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc Natl Acad Sci U S A 98(5):2723\u20138","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"6303_CR36","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/jm0491039","volume":"48","author":"L Nallan","year":"2005","unstructured":"Nallan L, Bauer KD, Bendale P, Rivas K, Yokoyama K, Horney CP, Pendyala PR, Floyd D, Lombardo LJ, Williams DK, Hamilton A, Sebti S, Windsor WT, Weber PC, Buckner FS, Chakrabarti D, Gelb MH, Van Voorhis WC (2005) Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. J Med Chem 48(11):3704\u20133713","journal-title":"J Med Chem"},{"issue":"2","key":"6303_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0020-7519(01)00111-4","volume":"31","author":"R McLeod","year":"2001","unstructured":"McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW (2001) Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol 31(2):109\u2013113","journal-title":"Int J Parasitol"},{"issue":"10","key":"6303_CR38","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1074\/jbc.M412693200","volume":"280","author":"LM Ting","year":"2005","unstructured":"Ting LM, Shi W, Lewandowicz A, Singh V, Mwakingwe A, Birck MR, Ringia EA, Bench G, Madrid DC, Tyler PC, Evans GB, Furneaux RH, Schramm VL, Kim K (2005) Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. J Biol Chem 280(10):9547\u20139554","journal-title":"J Biol Chem"},{"issue":"8","key":"6303_CR39","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1128\/AAC.48.8.3093-3102.2004","volume":"48","author":"X He","year":"2004","unstructured":"He X, Reeve AM, Desai UR, Kellogg GE, Reynolds KA (2004) 1,2-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH). Antimicrob Agents Chemother 48(8):3093\u20133102","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"6303_CR40","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","volume":"272","author":"IK Srivastava","year":"1997","unstructured":"Srivastava IK, Rottenberg H, Vaidya AB (1997) Atovaquone, a broad-spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem 272(7):3961\u20133966","journal-title":"J Biol Chem"},{"issue":"7","key":"6303_CR41","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.47.7.2108-2112.2003","volume":"47","author":"A Nzila","year":"2003","unstructured":"Nzila A, Mberu E, Bray P, Kokwaro G, Winstanley P, Marsh K, Ward S (2003) Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrob Agents Chemother 47(7):2108\u20132112","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"6303_CR42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmaid.2008.01.005","volume":"6","author":"AP Patel","year":"2008","unstructured":"Patel AP, Staines HM, Krishna S (2008) New antimalarial targets: the example of glucose transport. Travel Med Infect Dis 6(1\u20132):58\u201366","journal-title":"Travel Med Infect Dis"},{"issue":"11","key":"6303_CR43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2174\/0929867033457674","volume":"10","author":"C Boss","year":"2003","unstructured":"Boss C, Richard-Bildstein S, Weller T, Fischli W, Meyer S, Binkert C (2003) Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents. Curr Med Chem 10(11):883\u2013907","journal-title":"Curr Med Chem"},{"key":"6303_CR44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.20163","volume":"30","author":"R Ettari","year":"2010","unstructured":"Ettari R, Bova F, Zappala M, Grasso S, Micale N (2010) Falcipain-2 inhibitors. Med Res Rev 30:136\u2013167","journal-title":"Med Res Rev"},{"issue":"4","key":"6303_CR45","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/IAI.01533-06","volume":"75","author":"A Kumar","year":"2007","unstructured":"Kumar A, Kumar K, Korde R, Puri SK, Malhotra P, Chauhan V (2007) Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential. Infect Immun 75(4):2026\u20132034","journal-title":"Infect Immun"},{"issue":"4","key":"6303_CR46","doi-asserted-by":"crossref","first-page":"e1001383","DOI":"10.1371\/journal.pgen.1001383","volume":"7","author":"TD Van","year":"2011","unstructured":"Van TD, Daniel JP, Stephen FS, Daniel EN (2011) Identification and functional validation of the novel antimalarial resistance locus PF10-0355 in Plasmodium falciparum. PLoS Genet 7(4):e1001383","journal-title":"PLoS Genet"},{"key":"6303_CR47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"AB Sidhu","year":"2002","unstructured":"Sidhu AB, Verdier-Pinard D, Fidock DA (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210\u2013213","journal-title":"Science"},{"key":"6303_CR48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","volume":"27","author":"SG Valderramos","year":"2006","unstructured":"Valderramos SG, Fidock DA (2006) Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci 27:594\u2013601","journal-title":"Trends Pharmacol Sci"},{"issue":"15","key":"6303_CR49","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.91.15.7149","volume":"91","author":"T Triglia","year":"1994","unstructured":"Triglia T, Cowman AF (1994) Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci 91(15):7149\u20137153","journal-title":"Proc Natl Acad Sci"},{"key":"6303_CR50","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/514159","volume":"176","author":"CV Plowe","year":"1997","unstructured":"Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL (1997) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176:1590\u20131596","journal-title":"J Infect Dis"},{"key":"6303_CR51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4269\/ajtmh.2005.72.410","volume":"72","author":"X Wang","year":"2005","unstructured":"Wang X, Mu J, Li G, Chen P, Guo X, Fu L, Chen L, Su X, Wellems TE (2005) Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People\u2019s Republic of China. Am J Trop Med Hyg 72:410\u2013414","journal-title":"Am J Trop Med Hyg"},{"key":"6303_CR52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/1475-2875-12-395","volume":"12","author":"SA Ward","year":"2013","unstructured":"Ward SA, Boulton IC (2013) CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs. Malaria J 12:395","journal-title":"Malaria J"},{"key":"6303_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3201\/EID2003.121157","volume":"20","author":"G Vernet","year":"2014","unstructured":"Vernet G, Mary C, Altmann DM, Doumbo O, Morpeth S, Bhutta ZA, Klugman KP (2014) Surveillance for antimicrobial drug resistance in under-resourced countries. Emerg Infectious Dis 20:3","journal-title":"Emerg Infectious Dis"},{"issue":"8","key":"6303_CR54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","volume":"7","author":"L Cui","year":"2009","unstructured":"Cui L, Su XZ (2009) Discovery, mechanisms of action, and combination therapy of artemisinin. Expert Rev Anti-Infect Ther 7(8):999\u20131013","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"2","key":"6303_CR55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pt.2010.11.006","volume":"27","author":"XC Ding","year":"2011","unstructured":"Ding XC, Beck HP, Raso G (2011) Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol 27(2):73\u201381","journal-title":"Trends Parasitol"},{"key":"6303_CR56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mam.2004.02.021","volume":"25","author":"JF Turrens","year":"2004","unstructured":"Turrens JF (2004) Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. Mol Aspects Med 25:211\u2013220","journal-title":"Mol Aspects Med"},{"key":"6303_CR57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20070934","volume":"407","author":"N Klonis","year":"2007","unstructured":"Klonis N, Tan O, Jackson K, Goldberg D, Klemba M, Tilley L (2007) Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of hemoglobin in Plasmodium falciparum. Biochem J 407:343\u2013354","journal-title":"Biochem J"},{"key":"6303_CR58","first-page":"275","volume":"295","author":"DE Goldberg","year":"2005","unstructured":"Goldberg DE (2005) Hemoglobin degradation. Curr Top Microbiol Immunol 295:275\u2013291","journal-title":"Curr Top Microbiol Immunol"},{"key":"6303_CR59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpara.2003.09.011","volume":"34","author":"K Becker","year":"2004","unstructured":"Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H (2004) Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34:163\u2013189","journal-title":"Int J Parasitol"},{"key":"6303_CR60","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","volume":"74","author":"CD Fitch","year":"2004","unstructured":"Fitch CD (2004) Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci 74:1957\u20131972","journal-title":"Life Sci"},{"key":"6303_CR61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0166-6851(93)90069-A","volume":"61","author":"H Atamna","year":"1995","unstructured":"Atamna H, Ginsburg H (1995) Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 61:231\u2013241","journal-title":"Mol Biochem Parasitol"},{"key":"6303_CR62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbiopara.2007.11.005","volume":"157","author":"TJ Egan","year":"2008","unstructured":"Egan TJ (2008) Haemozoin formation. Mol Biochem Parasitol 157:127\u2013136","journal-title":"Mol Biochem Parasitol"},{"key":"6303_CR63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0169-4758(99)01502-1","volume":"15","author":"H Ginsburg","year":"1999","unstructured":"Ginsburg H, Ward SA, Bray PG (1999) An integrated model of chloroquine action. Parasitol Today 15:357","journal-title":"Parasitol Today"},{"key":"6303_CR64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","volume":"404","author":"S Pagola","year":"2000","unstructured":"Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK (2000) The structure of malaria pigment \u03b2-haematin. Nature 404:307\u2013310","journal-title":"Nature"},{"key":"6303_CR65","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","volume":"100","author":"E Hempelmann","year":"2007","unstructured":"Hempelmann E (2007) Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitol Res 100:671\u2013676","journal-title":"Parasitol Res"},{"issue":"5","key":"6303_CR66","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/med.20082","volume":"26","author":"K Ersmark","year":"2006","unstructured":"Ersmark K, Samuelsson B, Hallberg A (2006) Plasmepsins as potential targets for new antimalarial therapy. Med Res Rev 26(5):626\u2013666","journal-title":"Med Res Rev"},{"issue":"1","key":"6303_CR67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1389450003349461","volume":"1","author":"MJ Blackman","year":"2000","unstructured":"Blackman MJ (2000) Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets. Curr Drug Targets 1(1):59\u201383","journal-title":"Curr Drug Targets"},{"key":"6303_CR68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.micro.51.1.97","volume":"51","author":"SE Francis","year":"1997","unstructured":"Francis SE, Sullivan DJ, Goldberg DE (1997) Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51:97\u2013123","journal-title":"Annu Rev Microbiol"},{"issue":"41","key":"6303_CR69","doi-asserted-by":"crossref","first-page":"43000","DOI":"10.1074\/jbc.M408123200","volume":"279","author":"M Klemba","year":"2004","unstructured":"Klemba M, Gluzman I, Goldberg DE (2004) A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem 279(41):43000\u201343007","journal-title":"J Biol Chem"},{"issue":"1","key":"6303_CR70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-6851(01)00327-9","volume":"117","author":"CS Gavigan","year":"2001","unstructured":"Gavigan CS, Dalton JP, Bell A (2001) The role of aminopeptidases in hemoglobin degradation in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol 117(1):37\u201348","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"6303_CR71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.98.1.271","volume":"98","author":"BL Salmon","year":"2001","unstructured":"Salmon BL, Oksman A, Goldberg DE (2001) Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc Natl Acad Sci U S A 98(1):271\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6303_CR72","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/AAC.45.3.949-951.2001","volume":"45","author":"A Singh","year":"2001","unstructured":"Singh A, Rosenthal PJ (2001) Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum. Antimicrob Agents Chemother 45(3):949\u2013951","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"6303_CR73","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1073\/pnas.0502368102","volume":"102","author":"KC Pandey","year":"2005","unstructured":"Pandey KC, Wang SX, Sijwali PS, Lau AL, McKerrow JH, Rosenthal PJ (2005) The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci U S A 102(26):9138\u201343","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6303_CR74","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/febs.14130","volume":"284","author":"E Deu","year":"2017","unstructured":"Deu E (2017) Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation. FEBS J 284:2604\u20132628","journal-title":"FEBS J"},{"key":"6303_CR75","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrd3053","volume":"9","author":"M Drag","year":"2010","unstructured":"Drag M, Salvesen GS (2010) Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 9:690\u2013701","journal-title":"Nat Rev Drug Discov"},{"key":"6303_CR76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.pathol.1.110304.100151","volume":"1","author":"JH McKerrow","year":"2006","unstructured":"McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M (2006) Proteases in parasitic diseases. Annu Rev Pathol Mech Dis 1:497\u2013536","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"6303_CR77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio837","volume":"2","author":"AR Renslo","year":"2006","unstructured":"Renslo AR, McKerrow JH (2006) Drug discovery and development for neglected parasitic diseases. Nat Chem Biol 2:701\u2013710","journal-title":"Nat Chem Biol"},{"key":"6303_CR78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1475-2875-7-187","volume":"7","author":"A Kreidenweiss","year":"2008","unstructured":"Kreidenweiss A, Kremsner PG, Mordm\u00fcller B (2008) A comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J 7:187","journal-title":"Malar J"},{"key":"6303_CR79","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/febs.14029","volume":"284","author":"B Bibo-Verdugo","year":"2017","unstructured":"Bibo-Verdugo B, Jiang Z, Caffrey CR, O\u2019Donoghue AJ (2017) Targeting proteasomes in infectious organisms to combat disease. FEBS J 284:1503\u20131517","journal-title":"FEBS J"},{"key":"6303_CR80","doi-asserted-by":"crossref","first-page":"e73530","DOI":"10.1371\/journal.pone.0073530","volume":"8","author":"R Prasad","year":"2013","unstructured":"Prasad R, Atul-Kolla VK, Legac J, Singhal N, Navale R, Rosenthal PJ, Sijwali PS (2013) Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin-proteasome system by MG132. PLoS ONE 8:e73530","journal-title":"PLoS ONE"},{"key":"6303_CR81","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chembiol.2012.09.019","volume":"19","author":"H Li","year":"2012","unstructured":"Li H, Ponder EL, Verdoes M, Asbjornsdottir KH, Deu E, Edgington-Mitchell L, Lee JT, Kirk CJ, Demo SD, Williamson KC (2012) Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite- parasite-specific toxicity. Chem Biol 19:1535\u20131545","journal-title":"Chem Biol"},{"key":"6303_CR82","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1021\/ja507692y","volume":"136","author":"H Li","year":"2014","unstructured":"Li H, Tsu C, Blackburn C, Li G, Hales P, Dick L, Bogyo M (2014) Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome. J Am Chem Soc 136:13562\u201313565","journal-title":"J Am Chem Soc"},{"key":"6303_CR83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2018.04.007","volume":"198","author":"KM Krishnan","year":"2018","unstructured":"Krishnan KM, Williamson KC (2018) The proteasome as a target to combat malaria: Hits and misses. Transl Res 198:40\u201347","journal-title":"Transl Res"},{"key":"6303_CR84","first-page":"233","volume":"530","author":"H Li","year":"2016","unstructured":"Li H, O\u2019Donoghue AJ, van der Linden HL, Xie SC, Yoo E, Foe IT, Tilley L, Craik AJ, Da-Fonseca PC, Bogyo HL (2016) Structure and function-based design of Plasmodium-selective proteasome inhibitors. Nat Cell Biol 530:233\u2013236","journal-title":"Nat Cell Biol"},{"key":"6303_CR85","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/acs.jmedchem.9b00363","volume":"62","author":"W Zhan","year":"2019","unstructured":"Zhan W, Visone J, Ouellette T, Harris JC, Wang R, Zhang H, Singh PK, Ginn J, Sukenick G, Wong TT (2019) Improvement of asparagine ethylenediamines as antimalarial Plasmodium-selective proteasome inhibitors. J Med Chem 62:6137\u20136145","journal-title":"J Med Chem"},{"key":"6303_CR86","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1021\/acs.jmedchem.7b00671","volume":"60","author":"GM LaMonte","year":"2017","unstructured":"LaMonte GM, Almaliti J, Bibo-Verdugo B, Keller L, Zou BY, Yang J, Antonova-Koch Y, Orjuela-Sanchez P, Boyle CA, Vigil E (2017) Development of a potent inhibitor of the Plasmodium proteasome with reduced mammalian toxicity. J Med Chem 60:6721\u20136732","journal-title":"J Med Chem"},{"key":"6303_CR87","doi-asserted-by":"crossref","first-page":"e1007722","DOI":"10.1371\/journal.ppat.1007722","volume":"15","author":"BH Stokes","year":"2019","unstructured":"Stokes BH, Yoo E, Murithi JM, Luth MR, Afanasyev P, Da-Fonseca PC, Winzeler EA, Ng CL, Bogyo M, Fidock DA (2019) Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents. PLoS Pathog 15:e1007722","journal-title":"PLoS Pathog"},{"key":"6303_CR88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.exppara.2005.10.007","volume":"112","author":"N Singh","year":"2006","unstructured":"Singh N, Sijwali PS, Pandey KC, Rosenthal PJ (2006) Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2. Exp Parasitol 112:187\u2013192","journal-title":"Exp Parasitol"},{"issue":"3","key":"6303_CR89","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.bbrc.2005.07.147","volume":"335","author":"LL Goh","year":"2005","unstructured":"Goh LL, Sim TS (2005) Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum. Biochem Biophys Res Commun 335(3):762\u2013770","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"6303_CR90","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/molbev\/msg076","volume":"20","author":"KM Nielsen","year":"2003","unstructured":"Nielsen KM, Kasper J, Choi M, Bedford T, Kristiansen K, Wirth DF, Volkman SK, Lozovsky ER, Hartl DL (2003) Gene conversion as a source of nucleotide diversity in Plasmodium falciparum. Mol Biol Evol 20(5):726\u2013734","journal-title":"Mol Biol Evol"},{"issue":"1","key":"6303_CR91","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2958.2004.04108.x","volume":"53","author":"S Eksi","year":"2004","unstructured":"Eksi S, Czesny B, Greenbaum DC, Bogyo M, Williamson KC (2004) Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol Microbiol 53(1):243\u2013250","journal-title":"Mol Microbiol"},{"issue":"5600","key":"6303_CR92","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1126\/science.1077426","volume":"298","author":"DC Greenbaum","year":"2002","unstructured":"Greenbaum DC, Baruch A, Grainger M, Bozdech Z, Medzihradszky KF, Engel J, DeRisi J, Holder AA, Bogyo M (2002) A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298(5600):2002\u20132006","journal-title":"Science"},{"issue":"19","key":"6303_CR93","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1074\/jbc.M708949200","volume":"283","author":"ME Drew","year":"2008","unstructured":"Drew ME, Banerjee R, Uffman EW, Gilbertson S, Rosenthal PJ, Goldberg DE (2008) Plasmodium food vacuole plasmepsins are activated by falcipains. J Biol Chem 283(19):12870\u201312876","journal-title":"J Biol Chem"},{"issue":"23","key":"6303_CR94","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1073\/pnas.0402738101","volume":"101","author":"PS Sijwali","year":"2004","unstructured":"Sijwali PS, Kato K, Seydel KB, Gut J, Lehman J, Klemba M, Goldberg DE, Miller LH, Rosenthal PJ (2004) Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc Natl Acad Sci U S A 101(23):8721\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6303_CR95","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/092986711795328328","volume":"18","author":"C Teixeira","year":"2011","unstructured":"Teixeira C, Gomes JR, Gomes P (2011) Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. Curr Med Chem 18:1555\u20131572","journal-title":"Curr Med Chem"},{"issue":"3","key":"6303_CR96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/jm990412m","volume":"43","author":"D Leung","year":"2000","unstructured":"Leung D, Abbenante G, Fairlie DP (2000) Protease inhibitors: current status and prospects. J Med Chem 43(3):305\u2013341","journal-title":"J Med Chem"},{"key":"6303_CR97","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1073\/pnas.0600489103","volume":"103","author":"SX Wang","year":"2006","unstructured":"Wang SX, Pandey KC, Somoza JR, Sijwali PS, Kortemme T, Brinen LS, Fletterick RJ, Rosenthal PJ, McKerrow JH (2006) Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. Proc Natl Acad Sci U S A 103:11503\u201311508","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6303_CR98","doi-asserted-by":"crossref","first-page":"25425","DOI":"10.1074\/jbc.M603776200","volume":"281","author":"T Hogg","year":"2006","unstructured":"Hogg T, Nagarajan K, Herzberg S, Chen L, Shen X, Jiang H, Wecke M, Blohmke C, Hilgenfeld R, Schmidt CL (2006) Structural and functional characterization of falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum. J Biol Chem 281:25425\u201325437","journal-title":"J Biol Chem"},{"key":"6303_CR99","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","volume":"52","author":"ID Kerr","year":"2009","unstructured":"Kerr ID, Lee JH, Pandey KC, Harrison A, Sajid M, Rosenthal PJ, Brinen LS (2009) Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity. J Med Chem 52:852\u2013857","journal-title":"J Med Chem"},{"key":"6303_CR100","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","volume":"284","author":"ID Kerr","year":"2009","unstructured":"Kerr ID, Lee JH, Farady CJ, Marion R, Rickert M, Sajid M, Pandey KC, Caffrey CR, Legac J, Hansell E, McKerrow JH, Craik CS, Rosenthal PJ, Brinen LS (2009) Vinyl sulfones as antiparasitic agents: a structural basis for drug design. J Biol Chem 284:25697\u201325703","journal-title":"J Biol Chem"},{"issue":"1","key":"6303_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(01)00438-8","volume":"120","author":"M Sajid","year":"2002","unstructured":"Sajid M, McKerrow JH (2002) Cysteine proteases of parasitic organisms. Mol Biochem Parasitol 120(1):1\u201321","journal-title":"Mol Biochem Parasitol"},{"key":"6303_CR102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3600481","volume":"360","author":"PS Sijwali","year":"2001","unstructured":"Sijwali PS, Shenai BR, Gut J, Singh A, Rosenthal PJ (2001) Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J 360:481\u2013489","journal-title":"Biochem J"},{"key":"6303_CR103","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.M109680200","volume":"277","author":"PS Sijwali","year":"2002","unstructured":"Sijwali PS, Shenai BR, Rosenthal PJ (2002) Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain. J Biol Chem 277:14910\u201314915","journal-title":"J Biol Chem"},{"key":"6303_CR104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exppara.2019.01.005","volume":"197","author":"R Pasupureddy","year":"2019","unstructured":"Pasupureddy R, Verma S, Pant A, Sharma R, Seshadri S, Pande V, Saxena AK, Dixit R, Pandey KC (2019) Crucial residues in falcipains mediate hemoglobin hydrolysis. Exp Parasitol 197:43\u201350","journal-title":"Exp Parasitol"},{"key":"6303_CR105","doi-asserted-by":"crossref","first-page":"e5694","DOI":"10.1371\/journal.pone.0005694","volume":"4","author":"KC Pandey","year":"2009","unstructured":"Pandey KC, Barkan DT, Sali A, Rosenthal PJ (2009) Regulatory elements within the prodomain of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum. PLoS One 4:e5694","journal-title":"PLoS One"},{"key":"6303_CR106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2007.06.008","volume":"156","author":"PV Dasaradhi","year":"2007","unstructured":"Dasaradhi PV, Korde R, Thompson JK, Tanwar C, Nag TC, Chauhan VS, Cowman AF, Mohmmed A, Malhotra P (2007) Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 156:12\u201323","journal-title":"Mol Biochem Parasitol"},{"key":"6303_CR107","doi-asserted-by":"crossref","first-page":"24961","DOI":"10.1074\/jbc.M703316200","volume":"282","author":"S Subramanian","year":"2007","unstructured":"Subramanian S, Sijwali PS, Rosenthal PJ (2007) Falcipain cysteine proteases require bipartite motifs for trafficking to the Plasmodium falciparum food vacuole. J Biol Chem 282:24961\u201324969","journal-title":"J Biol Chem"},{"key":"6303_CR108","doi-asserted-by":"crossref","first-page":"e5156","DOI":"10.1371\/journal.pone.0005156","volume":"4","author":"S Subramanian","year":"2009","unstructured":"Subramanian S, Hardt M, Choe Y, Niles RK, Johansen EB, Legac J, Gut J, Kerr ID, Craik CS, Rosenthal PJ (2009) Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. PLoS One 4:e5156","journal-title":"PLoS One"},{"key":"6303_CR109","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2002-01-0101","volume":"100","author":"M Hanspal","year":"2002","unstructured":"Hanspal M, Dua M, Takakuwa Y, Chishti AH, Mizuno A (2002) Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100:1048\u20131054","journal-title":"Blood"},{"issue":"10","key":"6303_CR110","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0968-0896(03)00117-2","volume":"11","author":"S Batra","year":"2003","unstructured":"Batra S, Sabnis YA, Rosenthal PJ, Avery MA (2003) A structure-based approach to falcipain-2 inhibitors: synthesis and biological evaluation of 1,6,7-trisubstituted dihydro isoquinolines and isoquinolines. Bioorg Med Chem 11(10):2293\u20132299","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"6303_CR111","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","volume":"102","author":"JC Powers","year":"2002","unstructured":"Powers JC, Asian JL, Ekici OD, James KE (2002) Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem Rev 102(12):4639\u20134750","journal-title":"Chem Rev"},{"issue":"4","key":"6303_CR112","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156802606776287081","volume":"6","author":"R Vicik","year":"2006","unstructured":"Vicik R, Busemann M, Baumann K, Schirmeister T (2006) Inhibitors of cysteine proteases. Curr Top Med Chem 6(4):331\u2013353","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"6303_CR113","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/AAC.47.12.3810-3814.2003","volume":"47","author":"BJ Lee","year":"2003","unstructured":"Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ (2003) Antimalarial activities of novel synthetic cysteine protease inhibitors. Antimicrob Agents Chemother 47(12):3810\u20133814","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"6303_CR114","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/cmdc.200700070","volume":"2","author":"F Schulz","year":"2007","unstructured":"Schulz F, Gelhaus C, Degel B, Vicik R, Heppner S, Breuning A, Leippe M, Gut J, Rosenthal PJ, Schirmeister T (2007) Screening of protease inhibitors as antiplasmodial agents. Part I: aziridines and epoxides. Chem Med Chem 2(8):1214\u201324","journal-title":"Chem Med Chem"},{"key":"6303_CR115","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/jm100556b","volume":"53","author":"JM Coteron","year":"2010","unstructured":"Coteron JM, Catterick D, Castro J, Chaparro MJ, Diaz B, Fernandez E, Ferrer S, Gamo FJ, Gordo M, Gut J, de las Heras L, Legac J, Marco M, Miguel J, Munoz V, Porras E, de la Rosa JC, Ruiz JR, Sandoval E, Ventosa P, Rosenthal PJ, Fiandor JM (2010) Falcipain inhibitors: optimization studies of the 2- pyrimidine carbonitrile lead series. J Med Chem 53:6129\u20136152","journal-title":"J Med Chem"},{"key":"6303_CR116","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/AAC.42.9.2254","volume":"42","author":"A Semenov","year":"1998","unstructured":"Semenov A, Olson JE, Rosenthal PJ (1998) Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob Agents Chemother 42:2254\u20132258","journal-title":"Antimicrob Agents Chemother"},{"key":"6303_CR117","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1074\/jbc.REV120.009309","volume":"295","author":"AS Nasamu","year":"2020","unstructured":"Nasamu AS, Polino AJ, Istvan ES, Goldberg DE (2020) Malaria parasite plasmepsins: more than just plain old degradative pepsins. J Biol Chem 295:8425\u20138441","journal-title":"J Biol Chem"},{"issue":"2","key":"6303_CR118","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","volume":"99","author":"R Banerjee","year":"2002","unstructured":"Banerjee R, Liu J, Beatty W, Pelosof L, Klemba M, Goldberg DE (2002) Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci USA 99(2):990\u2013995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"6303_CR119","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1600-0854.2007.00589.x","volume":"8","author":"M Shea","year":"2007","unstructured":"Shea M, Jakle U, Liu Q, Berry C, Joiner KA, Soldati-Favre D (2007) A family of aspartic proteases and a novel, dynamic, and cell cycle-dependent protease localization in the secretory pathway of Toxoplasma gondii. Traffic 8(8):1018\u20131034","journal-title":"Traffic"},{"issue":"23","key":"6303_CR120","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.0601876103","volume":"103","author":"J Liu","year":"2006","unstructured":"Liu J, Istvan ES, Gluzman IY, Gross J, Goldberg DE (2006) Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc Natl Acad Sci USA 103(23):8840\u20138845","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"6303_CR121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2958.2007.05768.x","volume":"65","author":"JA Bonilla","year":"2007","unstructured":"Bonilla JA, Bonilla TD, Yowell CA, Fujioka H, Dame JB (2007) Critical roles for the digestive vacuole plasmepsins of plasmodium falciparum in vacuolar function. Mol Microbiol 65(1):64\u201375","journal-title":"Mol Microbiol"},{"issue":"14","key":"6303_CR122","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1073\/pnas.1218412110","volume":"110","author":"M Chugh","year":"2013","unstructured":"Chugh M, Sundararaman V, Kumar S, Reddy VS, Siddiqui A, Stuart KD (2013) Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc Natl Acad Sci USA 110(14):5392\u20135397","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"6303_CR123","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1074\/jbc.M109.063388","volume":"285","author":"F Li","year":"2010","unstructured":"Li F, Patra KP, Yowell CA, Dame JB, Chin K, Vinetz JM (2010) Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete. J Biol Chem 285(11):8076\u20138083","journal-title":"J Biol Chem"},{"issue":"5703","key":"6303_CR124","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1102452","volume":"306","author":"M Marti","year":"2004","unstructured":"Marti M, Good RT, Rug M, Knuepfer E, Cowman AF (2004) Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 306(5703):1930\u20131933","journal-title":"Science"},{"issue":"2","key":"6303_CR125","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/gb-2006-7-2-r12","volume":"7","author":"TJ Sargeant","year":"2006","unstructured":"Sargeant TJ, Marti M, Caler E, Carlton JM, Simpson K, Speed TP (2006) Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol 7(2):R12","journal-title":"Genome Biol"},{"issue":"2","key":"6303_CR126","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1432-1033.1997.00552.x","volume":"244","author":"RP Moon","year":"1997","unstructured":"Moon RP, Tyas L, Certa U, Rupp K, Bur D, Jacquet C (1997) Expression and characterization of plasmepsin I from Plasmodium falciparum. Eur J Biochem\/ FEBS 244(2):552\u2013560","journal-title":"Eur J Biochem\/ FEBS"},{"issue":"2","key":"6303_CR127","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","volume":"50","author":"KT Andrews","year":"2006","unstructured":"Andrews KT, Fairlie DP, Madala PK, Ray J, Wyatt DM, Hilton PM (2006) Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother 50(2):639\u2013648","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"6303_CR128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/156802612799362959","volume":"12","author":"MJ Meyers","year":"2012","unstructured":"Meyers MJ, Goldberg DE (2012) Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts. Curr Top Med Chem 12(5):445\u2013455","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"6303_CR129","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/jm020951i","volume":"46","author":"D Noteberg","year":"2003","unstructured":"Noteberg D, Hamelink E, Hulten J, Wahlgren M, Vrang L, Samuelsson B (2003) Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes. J Med Chem 46(5):734\u2013746","journal-title":"J Med Chem"},{"issue":"44","key":"6303_CR130","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1002\/anie.200903747","volume":"48","author":"K Liu","year":"2009","unstructured":"Liu K, Shi H, Xiao H, Chong AG, Bi X, Chang YT (2009) Functional profiling, identification, and inhibition of plasmepsins in intraerythrocytic malaria parasites. Angew Chem Int Ed Engl 48(44):8293\u20138297","journal-title":"Angew Chem Int Ed Engl"},{"issue":"23","key":"6303_CR131","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1016\/j.bmc.2008.10.011","volume":"16","author":"K Hidaka","year":"2008","unstructured":"Hidaka K, Kimura T, Ruben AJ, Uemura T, Kamiya M, Kiso A (2008) Antimalarial activity enhancement in hydroxymethyl carbonyl (HMC) isostere-based peptidomimetics targeting malarial aspartic protease plasmepsin. Bioorg Med Chem 16(23):10049\u201310060","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"6303_CR132","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1020155510718","volume":"16","author":"RD Taylor","year":"2002","unstructured":"Taylor RD, Jewsbury PJ, Essex JW (2002) A review of protein-small molecule docking methods. J Comput Aided Mol Des 16(3):151\u2013166","journal-title":"J Comput Aided Mol Des"},{"key":"6303_CR133","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","volume":"27","author":"P Favuzza","year":"2020","unstructured":"Favuzza P, de Lera RM, Thompson JK, Triglia T, Ngo A, Steel RW, Vavrek M, Christensen J, Healer J, Boyce C (2020) Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle. Cell Host Microbe 27:642-658.e12","journal-title":"Cell Host Microbe"},{"key":"6303_CR134","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.3390\/molecules27227915","volume":"27","author":"RO Kumi","year":"2022","unstructured":"Kumi RO, Oti B, Abo-Dya NE, Alahmdi MI, Soliman ME (2022) Bridging the gap in Malaria Parasite Resistance, current interventions, and the Way Forward from in Silico Perspective: A review. Molecules 27:7915","journal-title":"Molecules"},{"key":"6303_CR135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13321-024-00842-z","volume":"16","author":"NB Ncube","year":"2024","unstructured":"Ncube NB, Tukulula M, Govender KG (2024) Leveraging computational tools to combat malaria: assessment and development of new therapeutics. J Cheminformatics 16:50","journal-title":"J Cheminformatics"},{"key":"6303_CR136","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/biotech11040054","volume":"11","author":"S Nema","year":"2022","unstructured":"Nema S, Verma K, Mani A, Maurya NS, Tiwari A, Bhart PK (2022) Identification of potential antimalarial drug candidates targeting falcipain-2 protein of malaria parasite: a computational strategy. Biotech 11:54","journal-title":"Biotech"},{"key":"6303_CR137","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.3390\/ijms24119289","volume":"24","author":"SS Duay","year":"2023","unstructured":"Duay SS, Yap RC, Gaitano AL, Santos JA, Macalino SJ (2023) Roles of virtual screening and molecular dynamics simulations in discovering and understanding antimalarial drugs. Int J Mol Sci 24:9289","journal-title":"Int J Mol Sci"},{"key":"6303_CR138","doi-asserted-by":"crossref","first-page":"16380","DOI":"10.1038\/s41598-018-34622-1","volume":"8","author":"EO Salawu","year":"2018","unstructured":"Salawu EO (2018) In silico study reveals how E64 approaches, binds to, and inhibits falcipain-2 of Plasmodium falciparum that causes malaria in humans. Sci Rep 8:16380","journal-title":"Sci Rep"},{"key":"6303_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00146","author":"MN Lima","year":"2018","unstructured":"Lima MN, Melo-Filho CC, Cassiano GC, Neves BJ, Alves VM, Braga RC, Cravo PVL, Muratov EN, Calit J, Bargieri DY (2018) QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00146","journal-title":"Front Pharmacol"},{"key":"6303_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2941-5","volume":"18","author":"S Yousefinejad","year":"2019","unstructured":"Yousefinejad S, Mahboubifar M, Eskandari R (2019) Quantitative structureactivity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks. Malar J 18:1","journal-title":"Malar J"},{"key":"6303_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03550-9","volume":"20","author":"PT Nguyen","year":"2021","unstructured":"Nguyen PT, Van Dat T, Mizukami S, Nguyen DL, Mosaddeque F, Kim SN, Nguyen DHB, \u0110inh OT, Vo TL, Nguyen GLT et al (2021) 2D-quantitative structure\u2013activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds. Malar J 20:1","journal-title":"Malar J"},{"key":"6303_CR142","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/bi500060h","volume":"53","author":"K Arafet","year":"2014","unstructured":"Arafet K, Ferrer S, Marti S, Moliner V (2014) Quantum mechanics\/molecular mechanics studies of the mechanism of falcipain-2 inhibition by the epoxysuccinate E64. Biochemistry 53:3336\u20133346","journal-title":"Biochemistry"},{"key":"6303_CR143","doi-asserted-by":"crossref","first-page":"1070080","DOI":"10.3389\/fmolb.2022.1070080","volume":"9","author":"AU Danazumi","year":"2022","unstructured":"Danazumi AU, Balogun EO (2022) Microsecond-long simulation reveals the molecular mechanism for the dual inhibition of falcipain-2 and falcipain-3 by antimalarial lead compounds. Front Mol Biosci 9:1070080","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-025-06303-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:11:14Z","timestamp":1741601474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-025-06303-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":143,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6303"],"URL":"https:\/\/doi.org\/10.1007\/s00894-025-06303-0","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}